Nuago Therapeutics, Inc.
Biotechnology company · Chicago, Illinois, United States
Nuago Therapeutics, Inc. is a biotechnology company headquartered in Chicago, Illinois, United States. Its earliest recorded incorporation is in 2020. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $800,000 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $150,000 sold in a notice filed in 2022.
Nuago Therapeutics at a glance
What does Nuago Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $800,000 in total (2024 to 2025). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $150,000 sold (2022).
Frequently asked questions about Nuago Therapeutics
Where is Nuago Therapeutics headquartered?
Nuago Therapeutics, Inc. is headquartered in Chicago, Illinois, United States.
What does Nuago Therapeutics do?
Nuago Therapeutics, Inc. is a biotechnology company.
When was Nuago Therapeutics founded?
The earliest incorporation on record for Nuago Therapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- Metame Health Inc.Chicago, Illinois, United States
- Synapticure, Inc.Chicago, Illinois, United States
- BiomeSense, Inc.Chicago, Illinois, United States
- Inomagen Therapeutics, Inc.Chicago, Illinois, United States
- Advanced Cooling Therapy, Inc.Chicago, Illinois, United States
- Diagnostic Photonics, Inc.Chicago, Illinois, United States
- Microsensor Labs, LLCChicago, Illinois, United States
- Zuchem IncChicago, Illinois, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences